Iovance Biotherapeutics, Inc. IOVA Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s shares (diluted)?
- Iovance Biotherapeutics, Inc. (IOVA) reported shares (diluted) of 418.5M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s shares (diluted) changed year-over-year?
- Iovance Biotherapeutics, Inc.'s shares (diluted) increased by 29.6% year-over-year, from 322.9M to 418.5M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s shares (diluted)?
- Over 3 years (2021 to 2024), Iovance Biotherapeutics, Inc.'s shares (diluted) has grown at a 23.3% compound annual growth rate (CAGR), from 610M to 1.1B.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.